These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22855503)

  • 1. T cell signaling targets for enhancing regulatory or effector function.
    Pan F; Fan H; Liu Z; Jiang S
    Sci Signal; 2012 Jul; 5(235):pe32. PubMed ID: 22855503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.
    Beier UH; Wang L; Han R; Akimova T; Liu Y; Hancock WW
    Sci Signal; 2012 Jun; 5(229):ra45. PubMed ID: 22715468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deacetylase inhibition promotes the generation and function of regulatory T cells.
    Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
    Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.
    Beier UH; Akimova T; Liu Y; Wang L; Hancock WW
    Curr Opin Immunol; 2011 Oct; 23(5):670-8. PubMed ID: 21798734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T(reg) stability: to be or not to be.
    Overacre AE; Vignali DA
    Curr Opin Immunol; 2016 Apr; 39():39-43. PubMed ID: 26774863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
    Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
    Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3+ regulatory T cells in the human immune system.
    Sakaguchi S; Miyara M; Costantino CM; Hafler DA
    Nat Rev Immunol; 2010 Jul; 10(7):490-500. PubMed ID: 20559327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
    Marson A; Kretschmer K; Frampton GM; Jacobsen ES; Polansky JK; MacIsaac KD; Levine SS; Fraenkel E; von Boehmer H; Young RA
    Nature; 2007 Feb; 445(7130):931-5. PubMed ID: 17237765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.
    Feuerer M; Hill JA; Mathis D; Benoist C
    Nat Immunol; 2009 Jul; 10(7):689-95. PubMed ID: 19536194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.
    Swainson LA; Mold JE; Bajpai UD; McCune JM
    J Immunol; 2010 Apr; 184(7):3639-47. PubMed ID: 20190142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.
    Liu Y; Wang L; Predina J; Han R; Beier UH; Wang LC; Kapoor V; Bhatti TR; Akimova T; Singhal S; Brindle PK; Cole PA; Albelda SM; Hancock WW
    Nat Med; 2013 Sep; 19(9):1173-7. PubMed ID: 23955711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.
    Zheng Y; Chaudhry A; Kas A; deRoos P; Kim JM; Chu TT; Corcoran L; Treuting P; Klein U; Rudensky AY
    Nature; 2009 Mar; 458(7236):351-6. PubMed ID: 19182775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.
    Ono M
    Immunology; 2020 May; 160(1):24-37. PubMed ID: 32022254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
    Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3 modifies the phenotypic and functional properties of regulatory T cells.
    Campbell DJ; Ziegler SF
    Nat Rev Immunol; 2007 Apr; 7(4):305-10. PubMed ID: 17380159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity.
    Zhang H; Xiao Y; Zhu Z; Li B; Greene MI
    Immunol Cell Biol; 2012 Jan; 90(1):95-100. PubMed ID: 22124370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
    Collison LW; Workman CJ; Kuo TT; Boyd K; Wang Y; Vignali KM; Cross R; Sehy D; Blumberg RS; Vignali DA
    Nature; 2007 Nov; 450(7169):566-9. PubMed ID: 18033300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance.
    Wang L; Tao R; Hancock WW
    Immunol Cell Biol; 2009; 87(3):195-202. PubMed ID: 19172156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.